INFUSION SLEEVE
    3.
    发明申请
    INFUSION SLEEVE 审中-公开
    输液管

    公开(公告)号:WO1997028769A1

    公开(公告)日:1997-08-14

    申请号:PCT/US1997000746

    申请日:1997-01-09

    Abstract: An infusion sleeve having a two-piece body. The first piece is conical in shape and is attached to the handpiece by conventional methods. The distal end of the first piece contains a series of annular grooves. The second piece is tubular in shape and contains an annular rim or lip on the proximal end that interlocks within the annular grooves on the first piece.

    Abstract translation: 输液套管,具有两件式的身体。 第一件是圆锥形的,并且通过常规方法附接到手持件上。 第一件的远端包含一系列环形槽。 第二件是管状的,并且包括在近端上的环形边缘或唇缘,其在第一件上的环形槽内互锁。

    STABLE LIQUID ENZYME COMPOSITIONS AND METHODS OF USE
    8.
    发明申请
    STABLE LIQUID ENZYME COMPOSITIONS AND METHODS OF USE 审中-公开
    稳定的液体组合物和使用方法

    公开(公告)号:WO1996040853A1

    公开(公告)日:1996-12-19

    申请号:PCT/US1996009688

    申请日:1996-06-07

    CPC classification number: C11D3/38663 C11D3/0078

    Abstract: Compositions containing an ophthalmically acceptable enzyme of high purity and integrity in a liquid medium and methods involving the use of these compositions for cleaning a contact lens, and in combination with an antimicrobial agent for the simultaneous cleaning and disinfecting of contact lens are disclosed.

    Abstract translation: 公开了含有在液体介质中具有高纯度和完整性的眼科可接受的酶的组合物和涉及使用这些组合物用于清洁隐形眼镜的方法,以及与用于同时清洁和消毒隐形眼镜的抗微生物剂组合。

    USE OF TGF-'beta'3 TO REDUCE THE FORMATION OF SCAR TISSUE IN RESPONSE TO CORNEAL TRAUMA
    9.
    发明申请
    USE OF TGF-'beta'3 TO REDUCE THE FORMATION OF SCAR TISSUE IN RESPONSE TO CORNEAL TRAUMA 审中-公开
    TGF-β3用于减少脊髓组织在脊髓损伤中的形成

    公开(公告)号:WO1996032131A1

    公开(公告)日:1996-10-17

    申请号:PCT/US1995004572

    申请日:1995-04-14

    CPC classification number: A61K38/1841

    Abstract: The use of TGF- beta 3 to reduce the formation of scar tissue as a result of trauma to the cornea of the eye is described. The invention is particularly directed to the use of TGF- beta 3 to reduce the formation of scar tissue in connection with ophthalmic surgical procedures involving the cornea, such as laser irradiation of the cornea. A composition containing TGF- beta 3 is applied to the site of the trauma to alter the production and composition of extracellular matrix synthesized by fibroblasts, and thereby reduce the formation of scar tissue and consequent impairment of vision.

    Abstract translation: 描述了使用TGF-β3来减少由眼睛角膜创伤引起的瘢痕组织的形成。 本发明特别涉及使用TGF-β3来减少与涉及角膜的眼科手术相关的瘢痕组织的形成,例如角膜的激光照射。 将包含TGF-β3的组合物应用于创伤部位,以改变由成纤维细胞合成的细胞外基质的生成和组成,从而减少瘢痕组织的形成,从而减少视力。

    OPHTHALMIC COMPOSITIONS FOR TREATING GLAUCOMA
    10.
    发明申请
    OPHTHALMIC COMPOSITIONS FOR TREATING GLAUCOMA 审中-公开
    用于治疗玻璃体的眼科组合物

    公开(公告)号:WO1996022099A1

    公开(公告)日:1996-07-25

    申请号:PCT/US1995009144

    申请日:1995-07-20

    CPC classification number: C07D333/34 A61K45/06 C07D513/04

    Abstract: Ophthalmic pharmaceutical compositions useful in controlling elevated intraocular pressure associated with glaucoma and ocular hypertension are described. The compositions comprise a combination of a beta-blocker and a carbonic anhydrase inhibitor. Methods for controlling elevated intraocular pressure with these compositions are also described.

    Abstract translation: 描述了可用于控制与青光眼和眼高血压相关的升高的眼内压的眼用药物组合物。 组合物包含β-阻断剂和碳酸酐酶抑制剂的组合。 还描述了用这些组合物控制眼内压升高的方法。

Patent Agency Ranking